THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 119 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $492 | -16.6% | 57 | 0.0% | 0.00% | – |
Q2 2023 | $590 | -4.7% | 57 | 0.0% | 0.00% | – |
Q1 2023 | $619 | -38.1% | 57 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 57 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 57 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 57 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | – | 57 | 0.0% | 0.00% | – |
Q3 2021 | $0 | -100.0% | 57 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 57 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 57 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 57 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 57 | 0.0% | 0.00% | -100.0% |
Q1 2020 | $1,000 | – | 57 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
King Wealth Management Group | 22,500 | $583,000 | 0.15% |
Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |